Featured Slider

Four distinguished neurologists delivered the prestigious named lectures during the Presidential Symposium, held on the second day of EAN 2023.

The European Academy of Neurology (EAN) is a young society ready for the future, according to its president Prof. Paul Boon, who delivered his welcome address in the Opening Session on the first day of EAN 2023

Leading neurologists discussed how to promote brain health and overcome the global burden of brain disorders in a dedicated Studio Session on the first day of EAN 2023.

Programme Committee Chair, Ulf Kallweit, provides a preview of the 9th Annual Congress of the European Academy of Neurology, in Budapest on 1-4 July.

This month we have selected two papers of the month, reporting the results of two randomised, double-blind, placebo-controlled, phase III trials investigating potential therapies for generalised Myasthenia Gravis.

Each month the EANpages editorial team reviews the scientific press for recently published papers of outstanding interest to neurologists. Here we present our selection for June 2023.

EAN Scientific Committee Chair, Thomas Berger, reports on the new Cost-Conscious Healthcare project, the EAN Science School, and how EAN members can play a part in setting the EAN's scientific course.

Our paper of the month is a phase 1b, randomised, multicentre, placebo-controlled trial, which aims to investigate the safety, pharmacokinetics, and effects of MAPTRx in patients with mild Alzheimer's.

Each month the EANpages editorial team reviews the scientific press for recently published papers of outstanding interest to neurologists. Here we present our selection for May 2023.

EAN President, Paul Boon, on the forthcoming Brain Health Summit, EAN advocacy activities, the recent national societies forum, and more.

Our April paper of the month investigates the association between focal epilepsy and risk of incident dementia compared with patients with stroke or migraine and with healthy controls.

EAN Education Committee Chair, Irena Rektorová, gives an update on new projects, upcoming deadlines, and some exciting additions to existing educational programmes.

Our paper of the month presents the results of a prospective, double-blind, randomised, sham-controlled trial involving 16 centres and investigating the safety and efficacy of unilateral FUSA of the globus pallidus internus in patients with medication-refractory idiopathic PD.

President of the Turkish Neurological Society, shares a statement on the tragic aftermath of the earthquake in Türkiye and Syria and honours the memory of the neurologists lost.

EAN President, Paul Boon, provides an update on some upcoming major EAN events (including EAN 2023) and freshly launched EAN projects.